NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

The new Center for Recovery and Wellbeing and a Pathways to Recovery website seeks to break down barriers for those fighting addiction.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Reducing cravings is important because it lowers the likelihood of relapse and helps people stay committed to their recovery ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...